Authors: BARKSDALE CM NORDBLOM GD DUDECK RC WELTY DF JORDAN S BIGGE CF YI CS

Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID, Journal of clinical ligand assay, 21(3), 1998, pp. 324-330

Authors: BARKSDALE CM BURGER PJ NORDBLOM GD COOK JA KIRKISH LS MICHNIEWICZ BM DUDECK RC HODGES JC KLUTCHKO SR CONNOLLY CJC

Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR THE ORALLY-ACTIVE RENIN INHIBITOR CI-992 IN CYNOMOLGUS MONKEY AND HUMAN PLASMA, Journal of clinical ligand assay, 20(3), 1997, pp. 251-257

Authors: SIZEMORE N DUDECK RC BARKSDALE CM NORDBLOM GD MUELLER WT MCCONNELL P WRIGHT DS GUGLIETTA A KUO BS

Citation: N. Sizemore et al., DEVELOPMENT AND VALIDATION OF 2 SOLID-PHASE ENZYME IMMUNOASSAYS (ELISA) FOR QUANTITATION OF HUMAN EPIDERMAL GROWTH-FACTORS (HEGFS), Pharmaceutical research, 13(7), 1996, pp. 1088-1094

Authors: KUO BS NORDBLOM GD DUDECK RC KIRKISH LS WRIGHT DS

Citation: Bs. Kuo et al., DISPOSITION KINETICS OF HUMAN EPIDERMAL GROWTH-FACTOR (HEGF1-53) AND ITS TRUNCATED FRAGMENT (HEGF1-48) IN RATS, Drug metabolism and disposition, 24(1), 1996, pp. 96-104

Authors: KAGEL JR ROSSI DT NORDBLOM GD DUDECK RC BARKSDALE CM KUO BS WRIGHT DS

Citation: Jr. Kagel et al., CONSIDERATIONS IN THE DEVELOPMENT OF A SENSITIVE HPLC ASSAY FOR HUMANEPIDERMAL GROWTH-FACTORS IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 13(10), 1995, pp. 1205-1213